KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $52.8 million.

  • Medpace Holdings' Other Accumulated Expenses fell 148.98% to $52.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $52.8 million, marking a year-over-year decrease of 148.98%. This contributed to the annual value of $52.8 million for FY2025, which is 148.98% down from last year.
  • Latest data reveals that Medpace Holdings reported Other Accumulated Expenses of $52.8 million as of Q4 2025, which was down 148.98% from $54.3 million recorded in Q3 2025.
  • Medpace Holdings' Other Accumulated Expenses' 5-year high stood at $62.5 million during Q1 2023, with a 5-year trough of $21.2 million in Q2 2021.
  • Over the past 5 years, Medpace Holdings' median Other Accumulated Expenses value was $38.9 million (recorded in 2023), while the average stood at $39.9 million.
  • In the last 5 years, Medpace Holdings' Other Accumulated Expenses skyrocketed by 9693.91% in 2023 and then crashed by 2865.14% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Other Accumulated Expenses stood at $27.6 million in 2021, then surged by 72.2% to $47.5 million in 2022, then decreased by 14.95% to $40.4 million in 2023, then skyrocketed by 32.62% to $53.6 million in 2024, then decreased by 1.49% to $52.8 million in 2025.
  • Its Other Accumulated Expenses stands at $52.8 million for Q4 2025, versus $54.3 million for Q3 2025 and $44.9 million for Q2 2025.